Hans-Peter Brunner-La Rocca


Prof. Hans-Peter Brunner-La Rocca has graduated in medicine at the University of Zurich, Switzerland. He was trained in Internal Medicine and Cardiology in Switzerland. After doing a post-doc in Melbourne, Australia, for two years, he had been working as cardiologist and heart failure specialist in Zurich. In 2002, he moved to Basel, where he was responsible for the heart failure and heart transplant services. He has obtained his lecture qualification both in Zurich and in Basel and was announced as Professor in Basel Switzerland in 2008. Since 2009, he has been working at Maastricht UMC+ as Professor of Clinical Heart Failure. He is head of the heart failure clinic and head of the division of structural heart diseases.

He has been involved in numerous research projects since many years. In particular, he has a special interest in personalised medicine in heart failure using biomarkers and has successfully led international studies related to this topic. In addition, eHealth is an important focus of research. He has published >250 research articles.

He has been working as member of different working groups of the Heart Failure Association of the European Society of Cardiology and is board member of working group on heart failure in the Netherlands.

On the one hand, he is continuing his research on biomarker in heart failure for therapy guidance. He is collaborating internationally on this topic and is participating in several large international projects in this regard. On the other hand, he is leading an international consortium, aiming to develop a personalized eHealth application to enable patients with heart failure to perform self-care, i.e. including self-prescription of medication. Recently, the consortium received 4.4 M€ to support this project from INTERREG-NWE (budget Maastricht UMC+ > 2.0 M€).

He is additionally involved in national research projects (e.g. heart-brain connection, supported by CVON) and is the local PI of several large industry sponsored RCTs. In one of them, he is the national coordinator for the Netherlands.

Department of Cardiology
P. Debyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht
Room number: 3.B2.031
T: +31(0)43 387 70 97

  • 2022
    • Anker, S. D., Butler, J., Usman, M. S., Filippatos, G., Ferreira, J. P., Bocchi, E., Böhm, M., Rocca, H. P. B-L., Choi, D-J., Chopra, V., Chuquiure, E., Giannetti, N., Gomez-Mesa, J. E., Janssens, S., Januzzi, J. L., González-Juanatey, J. R., Merkely, B., Nicholls, S. J., Perrone, S. V., ... Zannad, F. (2022). Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved. Nature Medicine, 28, 2512–2520. https://doi.org/10.1038/s41591-022-02041-5
    • Kuipers, S., Greving, J. P., Brunner-La Rocca, H-P., Gottesman, R. F., van Oostenbrugge, R. J., Williams, N. L., Jan Biessels, G., Jaap Kappelle, L., & Heart-Brain Connection Consortium (2022). Risk evaluation of cognitive impairment in patients with heart failure: A call for action. IJC Heart and Vasculature, 43, [101133]. https://doi.org/10.1016/j.ijcha.2022.101133
    • Gingele, A. J., Boyne, J., Knackstedt, C., & Brunner-La Rocca, H. P. (2022). The MIS-HF in clinical practice. Netherlands Heart Journal, 30(12), 582-583. https://doi.org/10.1007/s12471-022-01731-6
    • Lim, Y. M. F., Molnar, M., Vaartjes, I., Savarese, G., Eijkemans, M. J. C., Uijl, A., Vradi, E., Suzart-Woischnik, K., Brugts, J. J., Brunner-La Rocca, H-P., Blanc-Guillemaud, V., Couvelard, F., Baudier, C., Dyszynski, T., Waechter, S., Lund, L. H., Hoes, A. W., Tyl, B., Asselbergs, F. W., ... Koudstaal, S. (2022). Generalizability of randomized controlled trials in heart failure with reduced ejection fraction. European heart journal. Quality of care & clinical outcomes, 8(7), 761–769. https://doi.org/10.1093/ehjqcco/qcab070
    • Raafs, A. G., Adriaans, B. P., Henkens, M. T. H. M., Verdonschot, J. A. J., Ramaekers, M. J. F. G., Gommers, S., Hamid, M. A. A., Schalla, S., Knackstedt, C., van Empel, V. P. M., Hans-Peter, B., Wildberger, J. E., Bekkers, S. C. A. M., & Hazebroek, M. R. (2022). Myocardial Fibrosis Assessment Using T1 and ECV Mapping With Histologic Validation in Chronic Dilated Cardiomyopathy. JACC-Cardiovascular Imaging, 15(10), 1828-1830. https://doi.org/10.1016/j.jcmg.2022.05.002
    • Herrmann, J. J., Beckers-Wesche, F., Baltussen, L. E. H. J. M., Verdijk, M. H. I., Bellersen, L., Brunner-la Rocca, H-P., Jaarsma, T., Pisters, R., Sanders-van Wijk, S., Rodwell, L., Van Royen, N., Gommans, D. H. F., & Van Kimmenade, R. R. J. (2022). Fluid REStriction in Heart Failure vs Liberal Fluid UPtake: Rationale and Design of the Randomized FRESH-UP Study. Journal of Cardiac Failure, 28(10), 1522-1530. https://doi.org/10.1016/j.cardfail.2022.05.015
    • Eurlings, C. G. M. J., Bektas, S., Sanders-van Wijk, S., Tsirkin, A., Vasilchenko, V., Meex, S. J. R., Failer, M., Oehri, C., Ruff, P., Zellweger, M. J., & Brunner-La Rocca, H-P. (2022). Use of artificial intelligence to assess the risk of coronary artery disease without additional (non-invasive) testing: validation in a low-risk to intermediate-risk outpatient clinic cohort. BMJ Open, 12(9), [e055170]. https://doi.org/10.1136/bmjopen-2021-055170
    • Gingele, A. J., Brandts, L., Brunner-La Rocca, H. P., Cleuren, G., Knackstedt, C., & Boyne, J. J. J. (2022). Introduction of a new scoring tool to identify clinically stable heart failure patients. Netherlands Heart Journal, 30(9), 402-410. https://doi.org/10.1007/s12471-021-01654-8
    • van Stipdonk, A. M. W., Schretlen, S., Dohmen, W., Knackstedt, C., Beckers-Wesche, F., Debie, L., Brunner-La Rocca, H-P., & Vernooy, K. (2022). Better outcome at lower costs after implementing a CRT-care pathway: comprehensive evaluation of real-world data. Esc heart failure, 9(4), 2518-2527. https://doi.org/10.1002/ehf2.13958
    • Vergaro, G., Gentile, F., Aimo, A., Januzzi, J. L., Richards, A. M., Lam, C. S. P., de Boer, R. A., Meems, L. M. G., Latini, R., Staszewsky, L., Anand, I. S., Cohn, J. N., Ueland, T., Gullestad, L., Aukrust, P., Brunner-La Rocca, H-P., Bayes-Genis, A., Lupón, J., Yoshihisa, A., ... Emdin, M. (2022). Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure. Esc heart failure, 9(4), 2084-2095. https://doi.org/10.1002/ehf2.13883